GlassScriptPhysician profile
Steven Jon Clark
NPI 1114952462
$3,470.74
in general payments reported to CMS, 2019-2025
11 companies · $1,630 in 2025
The $1,630 reported for 2025 was more than what 80% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.27 · 2020: $149 · 2021: $88.47 · 2022: $354 · 2023: $875 · 2024: $338 · 2025: $1,630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,650 · Travel and Lodging: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,649.93 |
| Travel and Lodging | $193.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,197.76 | 2021-2025 | |
| Mimedx Group, INC. | $1,137.23 | 2024-2025 | |
| Organogenesis INC. | $717.49 | 2020-2025 | Affinity, Nushield, Puraply |
| Grt US Holding, INC. | $122.32 | 2021-2022 | |
| Smith+Nephew, INC. | $77.92 | 2023-2025 | Grafix Pl |
| Averitas Pharma INC. | $64.56 | 2023-2024 | Qutenza |
| Kci USA, INC. | $51.80 | 2022-2023 | Prevena, V.A.C. Veraflo |
| Integra Lifesciences Corporation | $36.27 | 2019 | |
| Cornerstone Medical Associates, INC. | $27.24 | 2024 | |
| Tactile Systems Technology INC | $19.31 | 2021 | |
| Bone Support INC. | $18.84 | 2024 | Ceramentbone Void Filler, Cerament G |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.